1. Production of novel type of monoclonal antibody against cyclic GMP and its application to immunocytochemistry	FASEB 72th Annual Meeting	米国ラスベガス	1988
2. Site-directed mutagenesis of putative cAMP-binding sites of recombinant type I regulatory subunit of the cAMP-dependent protein kinase	FASEB 72th Annual Meeting	米国ラスベガス	1988
3. Activation of type I cAMP-dependent protein kinase is impared by a point mutation in cAMP binding sites.	7th International Conference on Cyclic Nucleotides, Calcium, and Protein Phosphorylation	神戸	1989
4. Regulation of a2 adrenergic receptor messenger RNA abundance by cAMP in HT-29 cells	FASEB 74th Annual Meeting	米国ワシントンDC	1990
5. A dominant- negative mutant of SOS1 inhibits insulin-induced p21ras and MAPK activation	15th International Diabetes Federation Congress	神戸	1994
6. Screening of the 3243 point mutation of mitochondrial DNA among Indonesian diabetics	DNC-JSPS symposium on Diabetes Mellitus	インドネシアジョグジャカルタ	1999
7.. In vivo administration of insulin from portal vein activates Akt and glycogen synthase, inhibits glycogen synthase kinase-3 (GSK-3) activity in the mouse skeletal muscle.	59th Scientific Sessions American Diabetes Association	米国サンディエゴ	1999

国際学会発表

BACK

NEXT